Drug Topics

DECEMBER 13, 2022

Relyvrio is intended to slow the disease progression of amyotrophic lateral sclerosis.

FDA

PhRMA

DECEMBER 15, 2022

Yet another study highlights the unintended consequences of the 340B program, which is increasing costs for patients and the health care system as a whole. In this case, the Berkeley Research Group (BRG) found that nearly 36% of all Medicare Part B therapy sales occurred at 340B hospitals in 2021 , up nearly 17 percentage points since 2012, meaning care is moving from physician offices and non-340B hospitals to 340B hospitals.

Hospitals

PharmaVoice

DECEMBER 16, 2022

A breakdown of how Twitter’s recent shifts are impacting pharma, and how the industry should navigate the platform in 2023.

STAT

DECEMBER 14, 2022

Hospice in America is gravely ill. An extensive investigation jointly published by The New Yorker and ProPublica documented outright fraud, predatory practices, and flagrant mistreatment by specific publicly traded and private equity-owned hospice companies.

Documentation

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

DECEMBER 12, 2022

When it comes to practicing pharmacy, do titles and degrees actually matter?

PhRMA

DECEMBER 14, 2022

A survey of more than 5,000 Americans conducted with Ipsos found that insured Americans want better health care coverage. These insights come from the third installment of the Patient Experience Survey and show how Americans favor policy solutions that improve their ability to navigate and access their care by seeking to remove barriers imposed by insurers and middlemen such as pharmacy benefit managers (PBMs).

Insurance

STAT

DECEMBER 14, 2022

Almost 90% of the health care companies deemed to be under financial stress by a leading credit rating agency are owned by private equity , a stark indicator of the toll financial investors have taken on a vital sector. The striking finding is part of a new Moody’s Investors Service report released this week that shows broad turbulence throughout an industry weakened by private equity’s practice of loading companies with debt, making them less resilient to challenges like Covid-19,

Hospitals

Drug Topics

DECEMBER 14, 2022

Job satisfaction is down and workplace stress is on the rise.

PhRMA

DECEMBER 12, 2022

If you or a loved one were to receive a diagnosis of a serious or life-threatening disease, you would likely want access to a U.S. Food and Drug Administration (FDA) approved safe and effective medicine as soon as possible. That’s precisely why the accelerated approval pathway was created back in 1992 at the urging of patient advocates. Since then, it has been a lifeline for millions of patients.

FDA

PharmaVoice

DECEMBER 12, 2022

A recent report ranks the top 20 pharma companies by how well they’re boosting a critical component of health equity.

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

DECEMBER 10, 2022

Whenever a hematopoietic cell transplant patient tries to get a family member to sneak food in past the nurses, Federico Stella, a resident hematologist at the University of Milan, remembers. One was a girl who tried to get her sister to bring her a panettone, a Milanese sweet bread usually eaten around the holidays. A week before Christmas, the sister tried to hide the panettone in a bag.

Drug Topics

DECEMBER 12, 2022

Investigators set out to evaluate how medication access for certain rheumatic conditions has changed since June 2022.

PhRMA

DECEMBER 14, 2022

Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important decisions about patient access to health care based on their determination of the value of new tests and treatments.

PharmaVoice

DECEMBER 13, 2022

As new and advanced therapies are revealed at the annual meeting of the American Society of Hematology this week, the patients are always at the center.

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

DECEMBER 12, 2022

Dapagliflozin (Farxiga) found effective in lowering the risk of hospitalization for patients with chronic kidney disease, with or without a diagnosis of type 2 diabetes, and increased the number of days alive and out of the hospital.

Hospitals

Drug Topics

DECEMBER 12, 2022

Online portals are accessible via tablet or computer and can streamline the mental health screening process.

Fierce Healthcare

DECEMBER 16, 2022

2023 forecast: Health tech tools begin constructing the Alzheimer's treatment plan. aburky. Fri, 12/16/2022 - 17:17.

PharmaVoice

DECEMBER 12, 2022

Learn why an informed, holistic view is needed to succeed in today’s complex and dynamic landscape.

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

DECEMBER 10, 2022

NEW ORLEANS — An emerging class of genetically targeted drugs is inducing remissions in about one-third of patients with advanced leukemia, according to updates Saturday from separate clinical trials. Two biotechs — Syndax Pharmaceuticals and Kura Oncology — are developing their own versions of so-called menin inhibitors that have the potential to become effective treatments for certain types of genetically defined acute myeloid leukemia (AML), a rapidly progressing bone mar

Drug Topics

DECEMBER 14, 2022

With the rise of cannabidiol (CBD) use, understanding how it can impact the effect of other medications is important.

Fierce Healthcare

DECEMBER 16, 2022

2023 forecast: Pharmacists push to take on a greater role in patient care. pminemyer. Fri, 12/16/2022 - 12:39.

Patient Care

PharmaVoice

DECEMBER 15, 2022

Steve Quake, science head at the Chan Zuckerberg Initiative, is leveraging personal experiences and a deep background in R&D to lead an ambitious 100-year plan.

Pharmacy Times

DECEMBER 14, 2022

Study finds gluten-free diets may play an important role in the causality of celiac disease on the development of psoriasis.

Drug Topics

DECEMBER 12, 2022

Haylea Hannah, MSPH, PhD, discusses her research on the barriers to medications for opioid use disorder that people who are incarcerated can face and what pharmacists can do to address the barriers.

Fierce Healthcare

DECEMBER 12, 2022

House and Senate Dems want CMS to drop ACO REACH members due to fraud concerns. rking. Mon, 12/12/2022 - 16:08.

pharmaphorum

DECEMBER 11, 2022

Digital transformation in pharma is not a singular endeavour. It can mean everything from patient-facing disease management apps and wearables to background AI dramatically altering drug discovery or radiological imaging. So, when a life sciences company embarks on a project of digital transformation or innovation, it’s really embarking on multiple projects that span the wide world of pharmaceutical operations.

Hospitals

Pharmacy Times

DECEMBER 15, 2022

Ryan Haumschild, PharmD, MS, MBA, leads a discussion surrounding myelodysplastic syndrome (MDS).

Drug Topics

DECEMBER 13, 2022

By offering resources such as free samples and generic alternatives, pharmacists can help patients lower costs.

PharmExec

DECEMBER 14, 2022

Perspectives from a board member and an aspiring board member on how to increase the number of qualified women on boards.

Fierce Pharma

DECEMBER 13, 2022

Cancer center leaders lay bare CAR-T makers' struggles—and an unexpected laggard. aliu. Tue, 12/13/2022 - 20:12.

Pharmacy Times

DECEMBER 15, 2022

Medical experts provide an overview on potential risk factors leading to MDS.

Drug Topics

DECEMBER 14, 2022

New pathways of care are needed to improve health care spending.

STAT

DECEMBER 10, 2022

NEW ORLEANS — Researchers had hoped in recent years that a protein called GPRC5D might offer a new way to get the immune system to hunt down and destroy multiple myeloma cells. Now, the results of a Phase 2 study on a bispecific antibody targeting this protein offers confirmation. The data, presented Saturday at the annual American Society of Hematology conferences, wowed a crowd of attendees, including clinicians who began excitedly imagining how to use the new drug in practice.

Immunization